Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2014 in TSC1/2 Mutated or Null Gastric Cancer
NCT03082833Phase 2Terminated
- Sponsor
- Samsung Medical Center
- Start
- Feb 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vistusertib in gastric cancer (GC), sponsored by Samsung Medical Center. Started Feb 2017; status: terminated.
02
Drugs
vistusertib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03082833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03082833.